X
Xiaoying Li
Researcher at Fudan University
Publications - 232
Citations - 12574
Xiaoying Li is an academic researcher from Fudan University. The author has contributed to research in topics: Diabetes mellitus & Insulin resistance. The author has an hindex of 42, co-authored 192 publications receiving 10218 citations. Previous affiliations of Xiaoying Li include Chinese Academy of Sciences & Xiamen University.
Papers
More filters
Journal ArticleDOI
The comparison of coronary angiographic profiles between diabetic and nondiabetic patients with coronary artery disease in a Chinese population.
TL;DR: Wang et al. as mentioned in this paper investigated angiographic profiles of the coronary arteries in diabetic CAD patients in comparison with nondiabetics, finding that the right coronary artery was significantly more frequently involved in the diabetics.
Journal ArticleDOI
Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease.
Yifei Zhang,Jie Hong,Weiqiong Gu,Ming-Hui Gui,Ying Chen,Yu Zhang,Zhen-ni Chi,Weiqing Wang,Xiaoying Li,Guang Ning +9 more
TL;DR: It is demonstrated that individual components of MetS and their various combinations may have different contributions to CHD and the severity of coronary artery stenosis and clinical focus should remain on establishing optimum-risk algorithms for CHD.
Journal ArticleDOI
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
Dalong Zhu,Xiaoying Li,Jianhua Ma,Jiao'e Zeng,Shenglian Gan,Xiaolin Dong,Jing-lu Yang,Xiao-hong Lin,Hanqing Cai,Weihong Song,Xuefeng Li,Keqin Zhang,Qiu Zhang,Yibing Lu,Ruifang Bu,Hui-Ge Shao,Guixia Wang,Guoyue Yuan,Xingwu Ran,L. Liao,Wenjuan Zhao,Ping Li,Zhaoshun Jiang,Yaoming Xue,Hongwei Jiang,Quanmin Li,Zongbao Li,Mao-Xiong Fu,Zerong Liang,Li'an Guo,Ming Liu,Chunrong Xu,Wenhui Li,Xue-Feng Yu,Guijun Qin,Zhou-fan Yang,Benli Su,Longyi Zeng,Houfa Geng,Yong-quan Shi,Yu Zhao,Yi Zhang,Wenying Yang,Li Chen +43 more
TL;DR: The SEED trial as discussed by the authors evaluated the efficacy and safety of dorzagliatin in patients with Type 2 diabetes (T2D) using a randomized, double-blind, placebo-controlled phase 3 clinical trial.
Journal ArticleDOI
MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3.
Xing Liu,Jiejie Zhao,Qi Liu,Xuelian Xiong,Zhijian Zhang,Yang Jiao,Xiaoying Li,Xiaoying Li,Bin Liu,Yao Li,Yan Lu,Yan Lu +11 more
TL;DR: It is shown that MicroRNA-124 was up-regulated in the livers of C57BL/6 mice fed a short-term high-fat-diet (HFD) and identified tribbles homolog 3 (TRB3) as a direct target of miR-124, which played a role in mediating high- Fat-Diet induced TG accumulation in the liver.
Journal ArticleDOI
Relationships between C-reactive protein, white blood cell count, and insulin resistance in a Chinese population
TL;DR: CRP might be a more effective biomarker in terms of the association with IR and individuals with both high levels of CRP and WBC were at higher risks of IR than those with high CRP or WBC alone.